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LIM -54, Hospital das Clínicas, 4) Institute of Tropical Medicine and 5) Department of Infectious Diseases, University of São Paulo, BrazilAbstractFusarium is considered an emerging pathogen, and there are few reports of fusariosis in children. The objective of this study was to describe
an outbreak of invasive fusariosis in a children’s cancer hospital. A neutropenic 17-year-old male patient hospitalized for 10 days for a relapse
of acute myeloid leukaemia, under chemotherapy, presented fever without any other symptoms; a thoracic computerized tomography
showed bilateral pulmonary nodules. During voriconazole treatment, 1-cm reddened and painful subcutaneous nodules appeared on arms
and legs and the culture of a skin biopsy revealed F. solani. Another case occurred 11 days later and started an outbreak investigation.
Water samples for cultures were collected from taps, showers and water reservoirs. Air from all patient rooms was sampled. Faucets
and the drains of sinks and showers were swabbed and cultured. Environmental and clinical isolates were typed. There were 10
conﬁrmed cases of infection caused by Fusarium spp. F. oxysporum and F. solani were isolated from water, swabs and air in patient rooms.
Many control measures were instituted, but the outbreak was only controlled 1 year after the ﬁrst case, when water ﬁlters ﬁltering 0.2
μm were installed at the exit of all faucets and showers in all patient rooms (points-of-use). Typing demonstrated that clinical isolates of
F. oxysporum were similar to those of the environment. In conclusion, to our knowledge this is the ﬁrst reported outbreak of invasive
fusariosis in children with oncohaematologic disease. It was controlled using 0.2-μm ﬁlters in all tap faucets and showers.
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E-mail: gcih.adm@hc.fm.usp.brIntroductionFungal infections in immune-compromised patients are a chal-
lenge with incurring severity and mortality. Although the fre-
quency of yeast infections has decreased, molds have increased
and Fusarium is an emerging pathogen [1]. More than 50 species of
Fusarium have been described, but only 12 species were found to
infect humans. Themost common are: F. solani (50%), F. oxysporum
(20%), F. verticillioidis, and F. moniliforme (10% each) [2].Microbiol Infect 2015; 21: 268.e1–268.e7
nical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2014.09.004Response of Fusarium infections to treatment depends on the
patient’s immune condition. In oncologic and haematologic
patients, especially those with prolonged periods of neu-
tropenia, the disease may be refractory [3]. Due to the rarity of
the disease, there is no consensus as to the best treatment.
Lipid amphotericin B, azoles (voriconazole, posaconazole) and
terbinaﬁne present in vitro activity [4]. Although caspofungin
presents poor in vitro activity, it may produce an effect in
combination [5].
There are few reports of invasive fusariosis in children. In an
international cohort study that enrolled 22 paediatric centres
and 131 children with invasive fungal disease, only 4 had Fusa-
rium infection [6]. There are 4 reports of fusariosis in children
with oncohaematologic disease, 2 of them using caspofungin
[7–10] and 2 reviews included some paediatric cases among theious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Litvinov et al. An outbreak of invasive fusariosis 268.e2predominant adults cases [1,5]. In a single paediatric centre,
only 5 cases of invasive fusariosis were described in 15 years
[7]. The objective of this study was to describe an outbreak of
invasive fusariosis in a children’s cancer hospital.Setting, index case and methodsHospital das Clínicas is a tertiary-care teaching hospital afﬁli-
ated with the University of São Paulo, with approximately 2000
beds distributed in various buildings. One building is a hospital
in which children with cancer are hospitalized or treated as
outpatients. The building was built in the 1970s but was unused
for 15 years before 2002. It has 3 ﬂoors in which patients
receive care. Between these 3 ﬂoors there are intermediate
ﬂoors for services, from which air conditioning and water
systems supply each ﬂoor below. There are also 2 ﬂoors below
street level. Hospitalization occurs in one ﬂoor with 15 indi-
vidual rooms, each with a bathroom and shower and windows
that open to the exterior; and 2 positive pressure rooms for
hematopoietic stem cell transplant patients which had not yet
received patients at the time of the outbreak. Plants are not
admitted in the entire hospital, thus they were not present in
the unit.An outbreak is suspectedOn April 24, 2009, a male 17-year-old patient hospitalized for 10
days for a relapse of acute myeloid leukaemia, under chemo-
therapy and presenting neutropenia, presented fever without
other symptoms. Cefepime and vancomycin were started, and as
fever persisted, amphotericin B. The antimicrobials were
changed to vancomycin, meropenem and voriconazole. Twelve
days later a thoracic computerized tomography (CT) showed
bilateral pulmonary nodules. On the 23rd day of fever, during
voriconazole treatment, 1-cm reddened and painful subcutane-
ous nodules appeared on his arms and legs. Culture of a skin
biopsy revealed F. solani. Another CT revealed hepatic and
splenic nodules but no central nervous system or sinus alter-
ations. When caspofungin was associated with voriconazole, the
skin lesions and CT images receded. The patient underwent a
successful allogeneic hematopoietic stem-cell transplant under
prophylactic voriconazole.
When another case was diagnosed 11 days after the ﬁrst
case, a case deﬁnition was created. A conﬁrmed case was
deﬁned as a patient with a positive culture for Fusarium ob-
tained from a usually sterile site plus clinical and/or radiologic
alterations compatible with fungal infection.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InOutbreak investigationSurveillance for new cases was initiated and included a retro-
spective search for cases in the previous 5 years. Two months
after the ﬁrst case, an inspection of the hospital was made in
which the patient areas were evaluated, as well as the infra-
structure of the building and services. One-litre water samples
for cultures were collected from taps, showers and the central
reservoirs. Air from all patient rooms was sampled using the
RCS Plus Air sampler during 10 minutes (volume: 500 m3) placed
at 1.5 m above the ﬂoor, using agar Sabouraud dextrose 2%
medium plastic strips, in situations we called dry and humid air.
Initially air was collected from the patient’s room (dry) and then
collected from the patient’s room during the ﬂow of the shower
in the adjacent bathroom (humid). The interior of faucets and
drains of sinks and showers were swabbed and cultured. We
evaluated all the patients and health care workers for the pres-
ence of onychomycosis or other superﬁcial fungal infections.
The following control measures were implemented in July
2009:
 Interruption of new admissions to the unit during 47 days
 Transfer of the hospitalized patients to another unit in
another building of the hospital
 Renovation of rooms and bathrooms with closure of the
communications between service ﬂoors and patient
rooms; ceiling panels were replaced with plaster ceilings
 Disconnection of central hot water reservoir and
installation of electric instant heating devices
 Cleaning of cold water reservoirs with chlorine and
continuous chlorination of water in the reservoirs (1.5
ppm) controlled by a chlorination device
 Filtration of water before entry into water reservoirs (10-
μm ﬁlters)
Water samples were collected 1.5 and 5 months later.
Approximately 10 months after the index case, water from
showers and reservoirs and air samples were cultured. In April
2010, 1 year after the ﬁrst case, 0.2-μm water ﬁlters were
installed at the exit of all faucets and showers in all rooms. After
the implementation of the control measures, prospective sur-
veillance for new cases was maintained.Microbiological methodsThe 1000-mL water samples were ﬁltered using 0.45-μm Mil-
lipore ﬁlters that were placed on agar Sabouraud dextrose (2%)
with chloramphenicol (14 mg%) and incubated at 30°C for 14fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 268.e1–268.e7
w
it
h
fu
sa
ri
o
si
s
du
ri
ng
an
o
ut
br
ea
k
in
a
ch
ild
re
n’
s
ca
nc
er
ho
sp
it
al
(A
pr
il
20
09
to
Ju
ne
20
11
)
4
(L
R
S
S
)
5
(G
R
O
)
6
(B
M
P
)
7
(G
G
P
)
8
(D
M
N
)
9
(F
W
J)
10
(L
S
C
)
Ju
ne
20
09
S
ep
te
m
be
r
20
09
Ja
nu
ar
y
20
10
Ju
ne
20
10
F
eb
ru
ar
y
20
11
M
ay
20
11
Ju
ne
20
11
Fe
m
al
e
M
al
e
Fe
m
al
e
M
al
e
Fe
m
al
e
M
al
e
M
al
e
10
m
os
8
y
16
y
8
y
16
y
9
y
13
y
A
LL
R
ef
ra
ct
or
y
A
LL
R
ef
ra
ct
or
y
A
M
L
A
M
L
R
el
ap
se
d
A
M
L
R
ef
ra
ct
or
y
A
LL
R
el
ap
se
d
A
LL
10
d
>
30
d
17
d
15
d
30
d
20
d
>
30
d
Sk
in
,l
un
g,
liv
er
,b
on
es
Sk
in
,l
iv
er
,s
pl
ee
n
Su
bc
ut
an
eo
us
no
du
le
s
Sk
in
,l
un
g,
liv
er
,b
on
es
Sk
in
,l
un
g,
liv
er
,
sp
le
en
,k
id
ne
ys
Sk
in
,l
un
g,
bo
ne
m
ar
ro
w
Sk
in
,l
un
g,
liv
er
,
sp
le
en
,k
id
ne
ys
,
bo
ne
m
ar
ro
w
Sk
in
bi
op
sy
Sk
in
bi
op
sy
Sk
in
bi
op
sy
Sk
in
bi
op
sy
Sk
in
bi
op
sy
,b
lo
od
Sk
in
bi
op
sy
,
bo
ne
m
ar
ro
w
Sk
in
bi
op
sy
,
bo
ne
m
ar
ro
w
Fu
sa
riu
m
sp
Fu
sa
riu
m
sp
Fu
sa
riu
m
sp
Fu
sa
riu
m
sp
Fu
sa
riu
m
sp
Fu
sa
riu
m
sp
Fu
sa
riu
m
sp
V
or
ic
on
az
ol
e
(4
m
g/
kg
tw
ic
e
da
ily
)
+
A
m
ph
o
D
(1
m
g/
kg
)
V
or
ic
on
az
ol
e
(4
m
g/
kg
tw
ic
e
da
ily
)
+
A
m
ph
o
D
(1
m
g/
kg
)
V
or
ic
on
az
ol
(2
00
m
g
tw
ic
e
da
ily
)
+
A
m
ph
o
D
(1
m
g/
kg
)
V
or
ic
on
az
ol
e
(8
m
g/
kg
tw
ic
e
da
ily
)
+
A
m
ph
o
Li
p
(5
m
g/
kg
)
V
or
ic
on
az
ol
e
(2
00
m
g
tw
ic
e
da
ily
)
+
A
m
ph
o
Li
p
(5
m
g/
kg
)
V
or
ic
on
az
ol
e
(8
m
g/
kg
tw
ic
e
da
ily
)
+
A
m
ph
o
Li
p
(3
m
g/
kg
)
V
or
ic
on
az
ol
e
(2
00
m
g
tw
ic
e
da
ily
)
+
A
m
ph
o
Li
p
(5
m
g/
kg
)
C
ur
e
D
ea
th
D
ea
th
C
ur
e
D
ea
th
D
ea
th
D
ea
th
is
D
ea
th
du
e
to
ba
ct
er
ia
ls
ep
si
s
D
ea
th
du
e
to
pr
og
re
ss
io
n
of
un
de
rl
yi
ng
di
se
as
e
an
d
to
fu
sa
ri
os
is
D
ea
th
du
e
to
pr
og
re
ss
io
n
of
un
de
rl
yi
ng
di
se
as
e
an
d
to
fu
sa
ri
os
is
U
nd
er
w
en
t
H
SC
T
C
ur
re
nt
ly
un
de
r
se
co
nd
ar
y
pr
op
hy
la
xi
s
D
ea
th
du
e
to
un
de
rl
yi
ng
di
se
as
e
an
d
to
fu
sa
ri
os
is
D
ea
th
du
e
to
un
de
rl
yi
ng
di
se
as
e
an
d
to
fu
sa
ri
os
is
D
ea
th
du
e
to
fu
sa
ri
os
is
m
ph
ot
er
ic
in
B
de
ox
yc
ho
la
te
;A
m
ph
o
Li
p,
lip
os
om
al
am
ph
ot
er
ic
in
;H
SC
T
,h
em
at
op
oi
et
ic
st
em
ce
ll
tr
an
sp
la
nt
.
268.e3 Clinical Microbiology and Infection, Volume 21 Number 3, March 2015 CMIdays. Suspect colonies were evaluated by microculture [12].
Swabs from drains and faucets were plated on agar Sabouraud
dextrose with chloranfenicol and processed as described
earlier. The strips obtained during air sampling were processed
as described earlier.
Isolates from patients were identiﬁed in the clinical labora-
tory of the hospital using an automated method (Vitek, bio-
Mérieux, Hazelwood, USA) as Fusarium sp. Sixteen
environmental and 3 clinical isolates from 2 patients were
evaluated for species determination. Partial EF gene was
ampliﬁed with primers EF1 (50-ATGGGTAAGGAAGACAA-
GAC-30) and EF2 (50- GGAAGTACCAGTGATCATGTT-30)
[13]. Puriﬁed polymerase chain reaction products were
sequenced by the dideoxy chain terminator method using the
Big Dye Terminator v3.1 cycle sequencing kit and a capillary
DNA sequencer ABI 3730 DNA Analyser from Applied Bio-
systems. The sequences were used as a query to BLAST the
GenBank database in a phylogenetic analysis. A 99% match
threshold cut-off was used to determine the species.
These 19 isolates were further studied to determine clon-
ality [14]. The evolutionary history was inferred by using the
Maximum Likelihood method based on the Tamura-Nei model
[15]. Initial tree(s) for the heuristic search were obtained
automatically by applying Neighbour-Join and BioNJ algorithms
to a matrix of pairwise distances estimated using the Maximum
Composite Likelihood approach, and then selecting the topol-
ogy with superior log likelihood value. The tree was drawn to
scale, with branch lengths measured in the number of sub-
stitutions per site. The analysis involved 19 nucleotide se-
quences. All positions containing gaps and missing data were
eliminated. There were a total of 583 positions in the ﬁnal
dataset. Evolutionary analyses were conducted using the
MEGA6.0 program [16].f
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iaThere were 10 conﬁrmed cases of infection caused by Fusarium
spp. from February 2009 to June 2011. There had been no
cases in the previous 5 years. The incidence density rates of
Fusarium infections in 2009, 2010 and 2011 were 1.04, 0.35 and
0.50 per 1000 patient-days, respectively; and the incidence
rates were 1.7, 0.67 and 1.2 per 100 admissions in 2009, 2010
and 2011, respectively.
The main characteristics of the cases can be seen in Table 1.
Most patients presented neutropenia and fever without a clear
infection site and showed no response to initial empirical
antimicrobial therapy. Nine of 10 patients developed painful and
erythematous skin nodules and presented involvement of
abdominal organs; 70% had pulmonary lesions. One patient onlyClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 268.e1–268.e7
CMI Litvinov et al. An outbreak of invasive fusariosis 268.e4presented a positive culture for Fusarium in the urine. The
computed tomography images did not show kidney lesions, and
the positive urine culture was interpreted as secondary to
fungemia, although blood cultures did not yield Fusarium. On
the other hand, the investigation of 2 other patients (patients 8
and 10 in Table 1) revealed kidney lesions. All patients were
treated with a combination of antifungal drugs until death of the
patient or disappearance of pulmonary lesions, after which
patients were put on secondary prophylaxis with oral vor-
iconazole. General mortality was 70% and mortality due to
fusariosis was 50%. The distribution of conﬁrmed cases over
the period in question is shown in Fig. 1. There were no cases
with cutaneous portal entry among patients and no cases of
onychomycosis or fungal skin conditions among health care
workers.Evaluation of the unitIn the 2 rooms for hematopoietic stem-cell transplant patients,
air was ﬁltered with high-efﬁciency particle air ﬁlters with 12 air
changes per hour, but they had not been used when the
outbreak occurred. In the other 15 rooms, there was a com-
mon air conditioning system with no special ﬁltering. The ceiling
of this unit consisted of removable panels with communicationFIG. 1. Distribution of conﬁrmed
cases of fusariosis that occurred
during an outbreak in a children’s
cancer hospital.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Inwith the service ﬂoors. On inspection there was a large
quantity of dirt and dust on these service ﬂoors.
The water in the taps and showers in the patient rooms
came from 3 reservoirs (40 000, 25 000 and 12 000 L) that
received water directly from the public water company. Water
was heated in a central reservoir with a gas heater. On in-
spection the water reservoirs were dirty and presented slime.
Maintenance had been neglected since 2006, but in February
2009 the reservoirs had been reportedly cleaned and treated
with a chlorine solution. The results of the initial environmental
cultures can be seen in Table 2. Six of the rooms had positive
water cultures for Fusarium. Air and environmental cultures
were positive in 3 rooms.
The water samples collected 1.5 and 5 months after the ﬁrst
investigation and after the implementation of the initial control
measures were negative. Ten months later, all water samples
(from rooms and reservoirs) were negative but 4 rooms had
positive swabs for Fusarium and 7 rooms presented positive air
cultures. This and the occurrence of 2 more conﬁrmed cases
led to the installation of 0.2-μm water ﬁlters on all faucets and
showers in all rooms.
Despite negative environmental cultures after the installation
of 0.2-μm water ﬁlters, 4 conﬁrmed cases still occurred.
However, these patients alternated hospital stays between 2
different hospitals and it was not clear where the acquisition offectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 268.e1–268.e7
TABLE 2. Environmental cultures performed during an outbreak of fusariosis in a children’s cancer hospital
Room
number
Cultures of
the water
Cultures of
swabs
Air
cultures
Cultures of water after
hyperchlorination
Cultures
June 2009 August 2009 January to March 2010
Shower Tap Drains and taps Dry Humid Shower Swabs Water Dry air Humid air
1 + + ND − − − − − + −
2 + + + + − − + − − +
3 + + + + + − − − − −
4 − − ND ND ND ND ND ND ND ND
5 − − ND ND ND − − − − −
6 − − ND ND ND − − − ND ND
7 + + + + − − − − + +
8 + + ND − − − − − − −
9 − − ND ND ND − − − − −
10 − − ND ND ND − − − − −
11 − − ND ND ND − − − + −
12 − − ND ND ND − + − − −
13 − − ND ND ND − + − − −
14 ND ND ND ND ND ND ND ND ND ND
15 − − ND − − − − − − +
Isolation room 1* ND ND ND ND ND − − − + −
Isolation room 2* + + − − − − + − + +
+, positive for Fusarium; −, negative for Fusarium; ND, not done; Humid, air collected during the ﬂow of the shower in the adjacent bathroom; Dry, air collected before the
shower was opened in the adjacent bathroom.
*For transplant patients.
268.e5 Clinical Microbiology and Infection, Volume 21 Number 3, March 2015 CMIFusarium may have occurred. Since July 2011 there have been
no more cases.
In summary, environmental cultures with positive results
were initiated in June 2009 through March 2010. After that they
were negative for Fusarium. The conﬁrmed cases occurred
from February 2009 through June 2011. Molecular typing of the
isolates showed an identical pattern for all F. oxysporum isolates
from the environment and patients 2 and 3 (Fig. 2). Among the
environmental F. solani isolates, there was high similarity.
However, patient 3 presented an F. solani isolate unrelated to
environmental isolates.DiscussionTo our knowledge, this is the ﬁrst report of an outbreak of
invasive fusariosis in a cancer hospital. There have been various
descriptions of outbreaks of keratitis due to contamination of
contact lens products [17,18] and of endophthalmitis after
cataract surgery [19,20]. There has been a description of a
pseudo-outbreak of F. solani related to contamination of a
bronchoscope [21].
This outbreak lasted 2 years including 10 conﬁrmed cases.
Water was deﬁned as the main source. Ample initial control
measures were not effective as new cases continued to occur.
Only the use of 0.2-μm ﬁlters in all tap faucets and showers
controlled the outbreak.
Molecular typing of the isolates showed similarity between
isolates from 2 patients and from the environment. One of
these patients presented isolates of 2 different species, one ofClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectwhich was related to the environmental isolates (F. oxysporum).
We believe that the typing method used in our study was
discriminatory [14,22].
The genus Fusarium is an environmental fungus disseminated
in the soil, air and water, common to tropical and temperate
areas [1]. Infection may occur as a result of inhalation of conidia
followed by hematogenous dissemination, or from direct
inoculation of skin or mucosae [1,23]. Although the most
common is the respiratory pathway, superﬁcial infections may
disseminate in immunocompromised hosts [1]. Thus, during
our investigation we evaluated all of the patients and health care
workers for the presence of onychomycosis or other skin
conditions, with negative results [24].
There are a number of studies that show that water can be a
source of infection in hospitalized patients. This is especially
true for Legionella and Pseudomonas. There are also studies
demonstrating colonization of water reservoirs in hospitals by
molds [25], including Fusarium [26]. A recently published
guideline on diagnosis and management of hyalohyphomycosis
[27] suggests investigation of tap water and bathrooms as an aid
in prevention of hospital-acquired infection. In our investigation
the fungus was identiﬁed in the water, suggesting that water was
the probable source of contamination. The colonization of the
water by fungi in an oncohaematologic hospital has been
demonstrated, and many genera were cultured from the water
(Cladosporium, Penicilium, Aspergillus) [28]. Another study using
molecular typing showed that a hospital water reservoir was
the source of invasive Fusarium infections [29], although a
Brazilian study comparing molecular typing of Fusarium in the
water system of a haematology hospital with samples ofious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 268.e1–268.e7
FIG. 2. Molecular phylogenetic analysis
of environmental and clinical isolates of
Fusarium oxysporum (Fo) and Fusarium
solani (Fs) by the Maximum Likelihood
method.
CMI Litvinov et al. An outbreak of invasive fusariosis 268.e6infected patients was unable to associate water contamination
and invasive fusariosis [30]. In this study, most clinical isolates
belonged to F. solani species complex, whereas environmental
isolates belonged to F. oxysporum species complex [30]. In our
outbreak, although F. oxysporum predominated in the environ-
ment, F. solani also occurred.
The optimal methods to control water contamination are
unclear. Some studies show that hyperchlorination and use of
electric showers are useful to control Legionella and other
bacteria in hospitals [31–33]. In our outbreak, these methods
were not effective, and although cultures of the water turned
negative, new cases of fusariosis occurred. This apparent
disparity may suggest that our immune-suppressed patients
were more sensitive than the cultures. Some studies show that
0.2-μm water ﬁlters at the point of use may decontaminate
water from molds [11,34,35]. In our outbreak, this seems to
have been the ultimate control method. Four cases occurred
after installing ﬁlters. We conducted an exhaustive investigation
and could not ﬁnd an explanation; however, these patients had
been treated in other institutions during their immunosup-
pression, making it not completely clear where the infection
had been acquired. These cases may weaken the hypothesis that
ﬁlters alone controlled the problem; however, there have been
no new cases for more than 3 years.
The clinical presentation of our conﬁrmed cases was similar
to that described in sporadic cases [1,2]. In all the patients,
prolonged neutropenia preceded the infection and most hadClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Inpainful cutaneous nodules, with central necrosis and visceral
abdominal involvement. Seven of 10 presented lung involve-
ment. Mortality in our series was similar to that described for
this infection, and most (7 of 10) had refractory underlying
disease leading to profound immune suppression. Interestingly
most patients did not present positive blood cultures.
Due to the severity of the infection in this population and
due to its high mortality, we believe that in units with high-risk
patients (oncology and haematology), prevention should be
emphasized with surveillance cultures for Fusarium of the
environment, mainly air and water, once cases have been
identiﬁed.
One of the limitations of our study was that only clinical
isolates from 2 patients were available for typing, the others
could not be recovered. Most, but not all, environmental iso-
lates were typed. Monitoring for plasmatic levels of vor-
iconazole was not done. In conclusion, this is to our knowledge
the ﬁrst reported outbreak of invasive fusariosis in children
with oncohaematologic disease. It was controlled by using 0.2-
μm ﬁlters in all tap faucets and showers.Transparency declarationThis study was funded in part by a grant by FAPESP (State of São
Paulo Foundation for the Promotion of Research) number
2012/02596-5.fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 268.e1–268.e7
268.e7 Clinical Microbiology and Infection, Volume 21 Number 3, March 2015 CMIAcknowledgementsThe authors are grateful to Marjorie Shafferman for her review
of the text.
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